Stöffler A - Search Results

1

A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500).

Wilcock G, Möbius HJ, Stöffler A; MMM 500 group. Wilcock G, et al. Among authors: stoffler a. Int Clin Psychopharmacol. 2002 Nov;17(6):297-305. doi: 10.1097/00004850-200211000-00005. Int Clin Psychopharmacol. 2002. PMID: 12409683 Clinical Trial.

2

A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease.

Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ. Reisberg B, et al. Among authors: stoffler a. Arch Neurol. 2006 Jan;63(1):49-54. doi: 10.1001/archneur.63.1.49. Arch Neurol. 2006. PMID: 16401736 Clinical Trial.

3

Memantine in vascular dementia.

Möbius HJ, Stöffler A. Möbius HJ, et al. Among authors: stoffler a. Int Psychogeriatr. 2003;15 Suppl 1:207-13. doi: 10.1017/S1041610203009219. Int Psychogeriatr. 2003. PMID: 16191242 Clinical Trial.

4

Memantine hydrochloride: pharmacological and clinical profile.

Möbius HJ, Stöffler A, Graham SM. Möbius HJ, et al. Among authors: stoffler a. Drugs Today (Barc). 2004 Aug;40(8):685-95. Drugs Today (Barc). 2004. PMID: 15510240 Clinical Trial.

5

Memantine in moderate-to-severe Alzheimer's disease.

Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ; Memantine Study Group. Reisberg B, et al. Among authors: stoffler a. N Engl J Med. 2003 Apr 3;348(14):1333-41. doi: 10.1056/NEJMoa013128. N Engl J Med. 2003. PMID: 12672860 Clinical Trial.

6

Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300).

Orgogozo JM, Rigaud AS, Stöffler A, Möbius HJ, Forette F. Orgogozo JM, et al. Among authors: stoffler a. Stroke. 2002 Jul;33(7):1834-9. doi: 10.1161/01.str.0000020094.08790.49. Stroke. 2002. PMID: 12105362 Clinical Trial.

7

Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's disease.

Wimo A, Winblad B, Stöffler A, Wirth Y, Möbius HJ. Wimo A, et al. Among authors: stoffler a. Pharmacoeconomics. 2003;21(5):327-40. doi: 10.2165/00019053-200321050-00004. Pharmacoeconomics. 2003. PMID: 12627986 Clinical Trial.

8

New approaches to clinical trials in vascular dementia: memantine in small vessel disease.

Möbius HJ, Stöffler A. Möbius HJ, et al. Among authors: stoffler a. Cerebrovasc Dis. 2002;13 Suppl 2:61-6. doi: 10.1159/000049153. Cerebrovasc Dis. 2002. PMID: 11901246 Clinical Trial.

9

Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease--a unified glutamatergic hypothesis on the mechanism of action.

Danysz W, Parsons CG, Mobius HJ, Stoffler A, Quack G. Danysz W, et al. Among authors: stoffler a. Neurotox Res. 2000;2(2-3):85-97. doi: 10.1007/BF03033787. Neurotox Res. 2000. PMID: 16787834

10

Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials.

Winblad B, Jones RW, Wirth Y, Stöffler A, Möbius HJ. Winblad B, et al. Among authors: stoffler a. Dement Geriatr Cogn Disord. 2007;24(1):20-7. doi: 10.1159/000102568. Epub 2007 May 10. Dement Geriatr Cogn Disord. 2007. PMID: 17496417 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results